Navigation Links
Journal Article Suggests DermaClose® RC Used in Combination With VAC Therapy Can Dramatically Reduce the Need for Skin Grafting of Fasciotomy Wounds for Combat Related Trauma
Date:3/22/2012

CHANHASSEN, Minn., March 22, 2012 /PRNewswire-iReach/ -- Wound Care Technologies, Inc. (www.dermaclose.com), an emerging medical technology company, today announced the publication of an invited review article by MAJ Benjamin K. Potter, MD, LTC Brett A. Freedman, MD, and Michael S. Shuler, MD, at Walter Reed National Military Medical Center, Bethesda, MD, describing their treatment for closing extremity fasciotomy wounds using the DermaClose® RC Continuous External Tissue Expander as it applies to the treatment of traumatic war injuries.

The article entitled, "Fasciotomy Wound Management and Closure" appears in the current issue of Techniques in Orthopedics® (Volume 27, Number 1, Lippincott Williams & Wolters, www.techortho.com). The authors describe how the use of vacuum-assisted closure (V.A.C., Kinetic Concepts, Inc., San Antonio, TX) in combination with dermatotraction is their preferred method to positively influence the rate of delayed primary closure of extremity fasciotomy wounds. Paul J. Anderson, President and CEO of Wound Care Technologies, Inc. said, "Thi speer reviewed published article continues to demonstrate the significant role of continuous external tissue expansion in the treatment of traumatic injuries".

About DermaClose RC®
DermaClose® RC is a continuous external tissue expander that facilitates rapid tissue movement to reduce or re-approximate wounds. The first-of-its-kind device utilizes skin anchors and a tension controller that applies a continuous controlled dynamic pulling force and does not require additional tightening after initial application. The tension will be maintained from hours to days until desired amount of expanded tissue is achieved and the device is removed.

About Wound Care Technologies, Inc.
Wound Care Technologies, Inc. (www.woundcaretech.com) is an emerging medical device company focused on the commercialization of its novel continuous external tissue expansion technology. The DermaClose RC® is the companies initial product and is currently marketed in the United States. For further information please contact Mr. Dennis L. Davey, VP of Sales and Marketing via email at ddavey@woundcaretech.com.

Media Contact: Dennis Davey, Wound Care Technologies, Inc., 612-325-9736, Ddavey@woundcaretech.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Wound Care Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. New England Journal of Medicine Article Reviews the Benefits of Ingenol Mebutate in Field Treatment of Actinic Keratoses
2. Generex Subsidiary Antigen Express Announces Publication of Review Showcasing its Proprietary Therapeutic Vaccine Technology in the Journal Vaccine
3. Data Published in the Journal of the American Society of Nephrology Shows Daily Home Hemodialysis Patients with the NxStage System One Have Significantly Lower Risk of Mortality and Improved 3-Year Survival Versus Patients on Conventional Hemodialys
4. Pivotal Data Demonstrating Efficacy of Plenadren® (Hydrocortisone, Modified Release Tablet) in Adrenal Insufficiency Published in the Journal of Clinical Endocrinology and Metabolism
5. Study Published in Neuro-Oncology Journal Shows Brain Tumor Eradication and Prolonged Survival in Mice Treated With Toca 511 and 5-FC
6. Aria Announces Publication of Independent Study in the American Journal of Obstetrics & Gynecology Using Arias Technology
7. National Pharmaceutical Council Debuts Column, "From Methods to Policy," In New Journal of Comparative Effectiveness Research
8. BioElectronics Study on Plantar Fasciitis to be Published in The Journal of Foot and Ankle Surgery
9. Results From Pilot Trial of PLCs RenalGuard® Published in International Journal of Cardiology
10. Journal of Cardiovascular Electrophysiology Study Shows Promising Single Ablation Procedure Outcomes With HeartLight EAS for Treatment of Atrial Fibrillation
11. OncoGenex Announces Publication of Phase I/II Custirsen (OGX-011/TV-1011) Data in Journal of Thoracic Oncology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... CHICAGO , Oct. 11, 2017  Hill-Rom Holdings, ... its Aspen Surgical facility in Las Piedras, ... surgical scalpels and blades. ... confirmed that the facility sustained minor structural damage, temporary ... Hurricane Maria. Repairs have been completed, manufacturing operations have ...
(Date:10/5/2017)... Oct. 5, 2017  In response to the ... and Maxillofacial Surgeons (AAOMS) released prescribing recommendations that ... be used as a first-line therapy to manage ... Recognizing the value and ... Paper "Opioid Prescribing: Acute and Postoperative Pain Management" ...
(Date:10/2/2017)... 2, 2017 Diplomat Pharmacy, Inc. (NYSE: ... and Consulting, LLC , and named its founder as ... in Tennessee , will operate under ... EnvoyHealth,s service offerings for health care partners to include ... "In an interoperable world, technology delivers ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer ... one of the most popular and least understood books in the Holy Scriptures, Revelation. ... descriptions that have baffled scholars for centuries. Many have tossed it off as mere ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains ... possible to save lost souls in the Philippines. “The Journey: From the Mountains to ... dedicated teacher of the Bible. She has taught all ages and currently teaches a ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 million ... by frequent cessation in breathing. Oral appliances can offer significant relief to about ...
(Date:10/12/2017)... ... ... IsoComforter, Inc. ( https://isocomforter.com ), one of the Nation’s premier ... of the shoulder pad. The shoulder pad provides optimal support and full contact ... using cold therapy. By utilizing ice and water that is circulated from an insulated ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: , ... to enable prevention of a major side effect of chemotherapy in children. Cisplatin ... patients. For cisplatin, hearing loss is FDA listed on-label as a dose limiting ...
Breaking Medicine News(10 mins):